CL2020003219A1 - Compuestos - Google Patents
CompuestosInfo
- Publication number
- CL2020003219A1 CL2020003219A1 CL2020003219A CL2020003219A CL2020003219A1 CL 2020003219 A1 CL2020003219 A1 CL 2020003219A1 CL 2020003219 A CL2020003219 A CL 2020003219A CL 2020003219 A CL2020003219 A CL 2020003219A CL 2020003219 A1 CL2020003219 A1 CL 2020003219A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- compound
- formula
- pharmaceutical salt
- pharmaceutical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto de fórmula (I), o una sal farmacéutica del mismo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810092.5A GB201810092D0 (en) | 2018-06-20 | 2018-06-20 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2020003219A1 true CL2020003219A1 (es) | 2021-06-11 |
Family
ID=63042663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2020003219A CL2020003219A1 (es) | 2018-06-20 | 2020-12-11 | Compuestos |
Country Status (41)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3471271A1 (en) | 2017-10-16 | 2019-04-17 | Acoustical Beauty | Improved convolutions of digital signals using a bit requirement optimization of a target digital signal |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| LT4299135T (lt) * | 2019-06-18 | 2025-09-10 | Pfizer Inc. | Benzizoksazolo sulfonamido dariniai |
| AU2020295006B2 (en) * | 2019-06-19 | 2023-11-09 | Ctxt Pty Ltd | Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives |
| US12012373B2 (en) | 2019-07-12 | 2024-06-18 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP4667055A3 (en) | 2020-07-15 | 2026-02-25 | Pfizer Inc. | Kat6 inhibitor methods and combinations for cancer treatment |
| JP2024521141A (ja) * | 2021-05-21 | 2024-05-28 | アウリジーン オンコロジー リミテッド | Ｋａｔ６ａ阻害剤としての縮合イソオキサゾリル化合物 |
| CN118382622A (zh) * | 2021-07-05 | 2024-07-23 | 杭州英创医药科技有限公司 | 作为kat6抑制剂的化合物 |
| CN117597341A (zh) * | 2021-08-10 | 2024-02-23 | 江苏恒瑞医药股份有限公司 | 磺酰胺衍生物、其制备方法及其在医药上的应用 |
| JP2024543512A (ja) | 2021-11-16 | 2024-11-21 | インシリコ メディシン アイピー リミテッド | リジンアセチルトランスフェラーゼ６ａ（ｋａｔ６ａ）阻害剤およびその使用 |
| US20250059204A1 (en) * | 2021-12-13 | 2025-02-20 | Aurigene Oncology Limited | Fused benzoisoxazolyl compounds as kat6a inhibitors |
| CN116621859A (zh) * | 2022-02-18 | 2023-08-22 | 山东轩竹医药科技有限公司 | 三并环类kat6抑制剂 |
| JP2025511122A (ja) * | 2022-03-28 | 2025-04-15 | アイソステリックス， インコーポレイテッド | リジンアセチルトランスフェラーゼのｍｙｓｔファミリーの阻害剤 |
| IL317668A (en) * | 2022-06-16 | 2025-02-01 | Prelude Therapeutics Inc | KAT6-targeted compounds with a ubiquitin ligase-binding residue |
| CN119604288A (zh) | 2022-07-29 | 2025-03-11 | 辉瑞大药厂 | 用于治疗癌症的包含kat6抑制剂的给药方案 |
| KR20250143814A (ko) | 2023-02-10 | 2025-10-02 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 설폰아미드 유도체 결정 형태 및 이의 제조 방법 |
| CN120981721A (zh) | 2023-03-30 | 2025-11-18 | 辉瑞大药厂 | Kat6a作为用kat6a抑制剂治疗的预测性生物标志物和相关治疗方法 |
| TW202446378A (zh) * | 2023-04-19 | 2024-12-01 | 香港商英矽智能科技知識產權有限公司 | 離胺酸乙醯基轉移酶6a(kat6a)抑制劑、其組合及其用途 |
| AU2024262206A1 (en) * | 2023-04-25 | 2025-12-04 | Insilico Medicine Ip Limited | Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof |
| TW202504580A (zh) * | 2023-07-04 | 2025-02-01 | 大陸商上海齊魯製藥研究中心有限公司 | Kat6抑制劑 |
| WO2025036382A1 (zh) * | 2023-08-14 | 2025-02-20 | 上海复宏汉霖生物医药有限公司 | 一种磺酰胺类化合物、其制备方法及用途 |
| WO2025098417A1 (zh) * | 2023-11-08 | 2025-05-15 | 再和医药科技（苏州）有限公司 | 磺酰胺类化合物及其应用 |
Family Cites Families (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3064003A (en) | 1962-11-13 | Carboxylic acid derivatives of sub- | ||
| US2358031A (en) | 1944-09-12 | Substituted thiadiazoles | ||
| US2525321A (en) | 1949-01-07 | 1950-10-10 | American Cyanamid Co | Hydroxybenzenesulfonamidoisoxazoles and preparation of same |
| GB689281A (en) | 1950-02-18 | 1953-03-25 | Lunbeck Corp | Improvements in or relating to the production of sulphanilamido-thiadiazoles |
| DE1102745B (de) | 1959-06-06 | 1961-03-23 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von 5-Sulfanilamidoisoxazolen |
| BE617370A (fr) | 1961-05-09 | 1962-11-08 | Ciba Geigy | Procédé de préparation du 2,5-di-[benzoxazolyl-(2')]-thiofène |
| US3332942A (en) | 1962-11-02 | 1967-07-25 | White Lab Inc | Substituted thiadiazoles |
| JPS498255B1 (es) | 1970-10-08 | 1974-02-25 | ||
| US3960854A (en) | 1972-03-20 | 1976-06-01 | Merck & Co., Inc. | 7-Mercapto(or thio)-benzothiadiazine products |
| US3951967A (en) | 1972-03-20 | 1976-04-20 | Merck & Co., Inc. | 7-Mercapto(or thio)-benzothiadiazine products |
| DE2617809C2 (de) | 1976-04-23 | 1984-09-20 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Stabilisierung von Chromdioxid-Magnetpigmenten und seine Verwendung |
| JPS6042794B2 (ja) | 1977-09-27 | 1985-09-25 | 三共株式会社 | イソオキサゾリウム塩，およびその製造方法 |
| US4251664A (en) | 1978-05-24 | 1981-02-17 | Henkel Corporation | Sulfonamidothiadiazoles, metal complexes thereof, and solutions containing such compounds for use in extraction of metal values |
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| JPS603685B2 (ja) | 1980-04-15 | 1985-01-30 | 日本コロムビア株式会社 | 絵入りレコ−ド盤の製造方法 |
| GB8427618D0 (en) | 1984-11-01 | 1984-12-05 | Shell Int Research | Anticoccidial compositions |
| JPS63238006A (ja) | 1987-03-26 | 1988-10-04 | Shionogi & Co Ltd | イモチ防除剤 |
| US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| NZ231534A (en) | 1988-11-29 | 1992-02-25 | Warner Lambert Co | 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions |
| JPH03258771A (ja) | 1990-03-09 | 1991-11-19 | Tosoh Corp | スルホンアミド誘導体、その製法及びそれを有効成分として含有する除草剤 |
| JP2902834B2 (ja) | 1991-10-09 | 1999-06-07 | 本田技研工業株式会社 | 自己伸縮型マウント |
| TW224462B (es) | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
| FR2690160A1 (fr) | 1992-04-15 | 1993-10-22 | Rhone Poulenc Rorer Sa | Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant. |
| NZ247440A (en) | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| FI941826L (fi) | 1993-04-21 | 1994-10-22 | Takeda Chemical Industries Ltd | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi |
| JP3901229B2 (ja) | 1994-05-13 | 2007-04-04 | Ｎｔｎ株式会社 | 耐熱・潤滑性樹脂組成物 |
| EP1048657A1 (en) | 1995-04-04 | 2000-11-02 | Texas Biotechnology Corporation | Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| JP4471404B2 (ja) | 1996-02-13 | 2010-06-02 | アストラゼネカ ユーケイ リミテッド | Ｖｅｇｆインヒビターとしてのキナゾリン誘導体 |
| ATE211134T1 (de) | 1996-03-05 | 2002-01-15 | 4-anilinochinazolin derivate | |
| US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| CA2271116A1 (en) | 1996-11-13 | 1998-05-22 | Gregory J. Wells | Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| WO1998035985A1 (en) | 1997-02-12 | 1998-08-20 | The Regents Of The University Of Michigan | Protein markers for lung cancer and use thereof |
| TR200202738T2 (tr) | 1997-04-28 | 2003-03-21 | Texas Biotechnology Corporation | Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler |
| US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| DK1553097T3 (da) | 1999-02-10 | 2010-12-13 | Astrazeneca Ab | Quinazolinderivat som angiogeneseinhibitor og mellemprodukter dertil |
| NZ517828A (en) | 1999-09-17 | 2003-10-31 | Millennium Pharm Inc | Inhibitors having activity against mammalian factor Xa |
| PL203782B1 (pl) | 1999-11-05 | 2009-11-30 | Astrazeneca Ab | Pochodne chinazoliny,sposoby ich wytwarzania,ich kompozycje farmaceutyczne oraz ich zastosowania |
| AU2456701A (en) | 1999-12-31 | 2001-07-16 | Texas Biotechnology Corporation | Pharmaceutical and veterinary uses of endothelin antagonists |
| DE122008000002I1 (de) | 2000-02-15 | 2008-04-17 | Sugen Inc | Pyrrol substituierte indolin-2-on protein kinase inhibitoren |
| AU2001250783A1 (en) | 2000-02-29 | 2001-09-12 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| JP2004502766A (ja) | 2000-07-07 | 2004-01-29 | アンギオジェン・ファーマシューティカルズ・リミテッド | 血管損傷剤としてのコルヒノール誘導体 |
| CA2410562A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| GB0127344D0 (en) | 2001-11-14 | 2002-01-02 | Cancer Res Ventures Ltd | Assay method |
| IL160630A0 (en) | 2001-11-22 | 2004-07-25 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| JP2003292485A (ja) | 2002-04-01 | 2003-10-15 | Yamanouchi Pharmaceut Co Ltd | スルホンアミド誘導体 |
| TW200505902A (en) | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| AU2004240885A1 (en) | 2003-05-21 | 2004-12-02 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| WO2004113310A1 (en) | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| BRPI0412876A (pt) | 2003-07-22 | 2006-10-03 | Janssen Pharmaceutica Nv | derivados de quinolinona como inibidores de c-fms quinase |
| KR20060073930A (ko) | 2003-08-08 | 2006-06-29 | 버텍스 파마슈티칼스 인코포레이티드 | 통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체 |
| US7615563B2 (en) | 2003-08-08 | 2009-11-10 | Gonzalez Iii Jesus E | Compositions useful as inhibitors of voltage-gated sodium channels |
| US7973161B2 (en) | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| US7642260B2 (en) | 2003-11-13 | 2010-01-05 | Abbott Laboratories, Inc. | Apoptosis promoters |
| US7767684B2 (en) | 2003-11-13 | 2010-08-03 | Abbott Laboratories | Apoptosis promoters |
| US8614318B2 (en) * | 2003-11-13 | 2013-12-24 | Abbvie Inc. | Apoptosis promoters |
| KR20070085340A (ko) | 2004-10-12 | 2007-08-27 | 디코드 제네틱스, 아이엔씨. | 폐쇄성 동맥 질환용의 아릴 설폰아미드 주변 치환된바이사이클릭 화합물 |
| CN101208314B (zh) | 2005-04-26 | 2010-12-08 | 海普尼昂公司 | 苯并异*唑哌嗪化合物及其使用方法 |
| BRPI0610258A2 (pt) | 2005-04-26 | 2012-09-25 | Hypnion Inc | composto ou um sal farmaceuticamente eficaz do mesmo, composição farmacêutica, e, uso de um composto |
| MX2007014486A (es) | 2005-05-16 | 2008-02-12 | Vertex Pharma | Derivados biciclicos como moduladores de canales ionicos. |
| DE102005038947A1 (de) | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| BRPI0616872A2 (pt) | 2005-10-06 | 2011-07-05 | Sanofi Aventis | [1,3,4]-tiadiazol-2il-amidas de ácido aril-sulfÈnico bicìclico, produto farmacêutico compreendendo os mesmos, uso e processo para a preparação do referido produto farmacêutico |
| CN101282951A (zh) | 2005-10-06 | 2008-10-08 | 塞诺菲-安万特股份有限公司 | N-[1,3,4]-噻二唑-2-基-苯磺酰胺，其制备方法以及其作为药物的应用 |
| DE102005055355A1 (de) | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
| CN101365686A (zh) | 2005-12-21 | 2009-02-11 | 沃泰克斯药物股份有限公司 | 作为离子通道调节剂的杂环衍生物 |
| DK2420494T3 (en) | 2006-08-16 | 2015-01-12 | J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone | Use of thiadiazole compounds as inhibitors of kynurenine 3-monooxygenase |
| US20080182845A1 (en) | 2006-11-16 | 2008-07-31 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| CA2670026A1 (en) | 2006-11-20 | 2008-05-29 | Alantos Pharmaceuticals Holding, Inc. | Heterotricyclic metalloprotease inhibitors |
| US20080194557A1 (en) | 2007-01-18 | 2008-08-14 | Joseph Barbosa | Methods and compositions for the treatment of pain, inflammation and cancer |
| WO2009012242A2 (en) | 2007-07-13 | 2009-01-22 | Icagen, Inc. | Sodium channel inhibitors |
| WO2009058348A1 (en) | 2007-11-01 | 2009-05-07 | Sirtris Pharmaceuticals, Inc. | Amide derivatives as sirtuin modulators |
| US8642660B2 (en) | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009080223A1 (en) | 2007-12-26 | 2009-07-02 | Sanofi-Aventis | Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| CA2734254C (en) | 2008-08-13 | 2018-06-05 | Smed-Ta/Td, Llc | Orthopaedic screws |
| WO2010046780A2 (en) | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
| EA020460B1 (ru) * | 2009-01-12 | 2014-11-28 | Пфайзер Лимитед | Производные сульфонамида |
| WO2010121963A1 (en) | 2009-04-21 | 2010-10-28 | Nerviano Medical Sciences S.R.L. | Resorcinol derivatives as hsp90 inhibitors |
| UA107360C2 (en) | 2009-08-05 | 2014-12-25 | Biogen Idec Inc | Bicyclic aryl sphingosine 1-phosphate analogs |
| PT2471786E (pt) | 2009-08-07 | 2016-03-04 | Hoffmann La Roche | Derivado de aminopirazol |
| US20130022629A1 (en) | 2010-01-04 | 2013-01-24 | Sharpe Arlene H | Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
| WO2011085575A1 (zh) | 2010-01-15 | 2011-07-21 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| CN101747325A (zh) | 2010-01-15 | 2010-06-23 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| CN101845043A (zh) | 2010-01-15 | 2010-09-29 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| CA2797694A1 (en) | 2010-04-29 | 2011-11-03 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Activators of human pyruvate kinase |
| TW201210597A (en) | 2010-06-09 | 2012-03-16 | Gilead Sciences Inc | Inhibitors of hepatitis C virus |
| WO2012007868A2 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
| JP5937102B2 (ja) | 2010-12-14 | 2016-06-22 | エレクトロフォレティクス リミテッド | カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤 |
| WO2012088438A1 (en) | 2010-12-22 | 2012-06-28 | Eutropics Pharmaceuticals, Inc. | Compositions and methods useful for treating diseases |
| US9464065B2 (en) | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| PL220630B1 (pl) | 2012-12-28 | 2015-11-30 | Inst Immunologii I Terapii Doświadczalnej Pan | Nowe sulfonamidowe pochodne izoksazolo[5,4-b]pirydyny o aktywności przeciwbakteryjnej, sposób ich wytwarzania oraz nowe zastosowanie 3-aminoizoksazolo[5,4-b]pirydyny |
| US9493429B2 (en) | 2013-03-15 | 2016-11-15 | Genentech, Inc. | Substituted benzoxazoles and methods of use thereof |
| WO2015102929A1 (en) | 2013-12-30 | 2015-07-09 | Novartis Ag | Tricyclic sulfonamide derivatives |
| EP3097101B1 (en) | 2014-01-24 | 2020-12-23 | Merck Sharp & Dohme Corp. | Isoquinoline derivatives as mgat2 inhibitors |
| JP6442485B2 (ja) * | 2014-04-23 | 2018-12-19 | 田辺三菱製薬株式会社 | 新規二環性または三環性複素環化合物 |
| JP5900759B2 (ja) | 2014-09-25 | 2016-04-06 | Toto株式会社 | 小便器 |
| CU20170105A7 (es) | 2015-02-24 | 2017-10-05 | Pfizer | Derivados de nucleosidos sustituidos útiles como agentes antineoplásicos |
| GB201510019D0 (en) | 2015-06-09 | 2015-07-22 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| WO2017002120A1 (en) | 2015-07-02 | 2017-01-05 | Yeda Research And Development Co. Ltd. | Selective inhibitors of senescent cells and uses thereof |
| WO2017098421A1 (en) | 2015-12-08 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Benzothiadiazine compounds |
| CN107098846B (zh) | 2016-02-26 | 2020-10-09 | 中国医学科学院药物研究所 | N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途 |
| MA46589A (fr) | 2016-10-24 | 2019-08-28 | Yumanity Therapeutics Inc | Composés et utilisations de ces derniers |
| US20220267260A1 (en) * | 2016-11-29 | 2022-08-25 | Epizyme, Inc. | Compounds containing a sulfonic group as kat inhibitors |
| WO2018226976A1 (en) | 2017-06-08 | 2018-12-13 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with mll proteins |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| LT4299135T (lt) * | 2019-06-18 | 2025-09-10 | Pfizer Inc. | Benzizoksazolo sulfonamido dariniai |
-
2018
- 2018-06-20 GB GBGB1810092.5A patent/GB201810092D0/en not_active Ceased
-
2019
- 2019-06-20 LT LTEPPCT/EP2019/066337T patent/LT3810602T/lt unknown
- 2019-06-20 PE PE2020001917A patent/PE20210181A1/es unknown
- 2019-06-20 MX MX2020012723A patent/MX2020012723A/es unknown
- 2019-06-20 GE GEAP202215535A patent/GEAP202215535A/en unknown
- 2019-06-20 HR HRP20231467TT patent/HRP20231467T1/hr unknown
- 2019-06-20 DK DK19734722.2T patent/DK3810602T3/da active
- 2019-06-20 MY MYPI2020006108A patent/MY208377A/en unknown
- 2019-06-20 IL IL279554A patent/IL279554B2/en unknown
- 2019-06-20 CR CR20210032A patent/CR20210032A/es unknown
- 2019-06-20 CU CU2020000096A patent/CU20200096A7/es unknown
- 2019-06-20 KR KR1020217001354A patent/KR102868724B1/ko active Active
- 2019-06-20 EP EP19734722.2A patent/EP3810602B1/en active Active
- 2019-06-20 CA CA3101238A patent/CA3101238A1/en active Pending
- 2019-06-20 SG SG11202010450VA patent/SG11202010450VA/en unknown
- 2019-06-20 US US16/446,868 patent/US20200039945A1/en not_active Abandoned
- 2019-06-20 HU HUE19734722A patent/HUE064744T2/hu unknown
- 2019-06-20 UY UY0001038270A patent/UY38270A/es active IP Right Grant
- 2019-06-20 WO PCT/EP2019/066337 patent/WO2019243491A1/en not_active Ceased
- 2019-06-20 MD MDE20210392T patent/MD3810602T2/ro unknown
- 2019-06-20 FI FIEP19734722.2T patent/FI3810602T3/fi active
- 2019-06-20 PY PY201901948644A patent/PY1948644A/es unknown
- 2019-06-20 TW TW108121417A patent/TWI826471B/zh active
- 2019-06-20 AU AU2019289888A patent/AU2019289888A1/en not_active Abandoned
- 2019-06-20 PL PL19734722.2T patent/PL3810602T3/pl unknown
- 2019-06-20 PT PT197347222T patent/PT3810602T/pt unknown
- 2019-06-20 MA MA52948A patent/MA52948B1/fr unknown
- 2019-06-20 JP JP2020571368A patent/JP2021529738A/ja not_active Withdrawn
- 2019-06-20 ES ES19734722T patent/ES2967983T3/es active Active
- 2019-06-20 RS RS20231178A patent/RS64932B1/sr unknown
- 2019-06-20 EP EP23202715.1A patent/EP4335439A3/en not_active Withdrawn
- 2019-06-20 SI SI201930674T patent/SI3810602T1/sl unknown
- 2019-06-20 CN CN201980041013.4A patent/CN112334466B/zh active Active
- 2019-06-20 GE GEAP201915535A patent/GEP20227403B/en unknown
- 2019-06-20 EA EA202092451A patent/EA202092451A1/ru unknown
- 2019-06-20 BR BR112020025869-5A patent/BR112020025869A2/pt unknown
- 2019-06-21 AR ARP190101711A patent/AR114972A1/es unknown
-
2020
- 2020-11-23 EC ECSENADI202075270A patent/ECSP20075270A/es unknown
- 2020-11-24 CO CONC2020/0014586A patent/CO2020014586A2/es unknown
- 2020-12-02 NI NI202000092A patent/NI202000092A/es unknown
- 2020-12-09 PH PH12020500673A patent/PH12020500673A1/en unknown
- 2020-12-11 CL CL2020003219A patent/CL2020003219A1/es unknown
- 2020-12-17 DO DO2020000249A patent/DOP2020000249A/es unknown
-
2021
- 2021-08-03 US US17/392,356 patent/US12365655B2/en active Active
-
2024
- 2024-07-05 JP JP2024108906A patent/JP7692095B2/ja active Active
- 2024-12-10 AU AU2024278273A patent/AU2024278273A1/en active Pending
-
2025
- 2025-06-18 US US19/241,736 patent/US20260062393A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020003219A1 (es) | Compuestos | |
| MX380394B (es) | Compuesto novedoso de bifenilo o una sal del mismo. | |
| AR101995A1 (es) | COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6 | |
| CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
| CO2019005165A2 (es) | Compuesto de piridona como inhibidor de c-met | |
| AR108711A1 (es) | Compuestos moduladores de fxr (nr1h4) | |
| EA202193015A1 (ru) | Ингибиторы cdk | |
| UY36314A (es) | NUEVOS COMPUESTOS ANTAGONISTAS DE INTEGRINA avß6. | |
| CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
| CL2017002090A1 (es) | Inhibidores selectivos de bace1 | |
| AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
| SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| EA201990238A1 (ru) | ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC | |
| ECSP18038014A (es) | Bloqueador del canal de sodio | |
| AR110770A1 (es) | Moduladores del canal de potasio | |
| MX2021009261A (es) | Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1. | |
| CL2022001511A1 (es) | Procesos e intermediario para la preparación de oxetan-2-ilmetanamina | |
| EA202190989A1 (ru) | Новый способ синтеза производных пиперазинил-этокси-бромфенила и их применение в получении содержащих их соединений | |
| AR115865A2 (es) | Compuestos terapéuticos | |
| AR125853A2 (es) | Composición farmacéutica de una sal hemisulfato de un compuesto nucleotídico | |
| CY1119316T1 (el) | Υδροχλωρικα αλατα μιας αντιβιοτικης ενωσης | |
| AR112111A1 (es) | Tetrahidropiridopirazinas moduladoras de receptores gpr6 | |
| UA127754U (uk) | Поліетергуанідингідрохлорид як бактерицидна речовина |